Download PDF
Aktuelle Rheumatologie 2018; 43(02): 156-160
DOI: 10.1055/s-0043-118005
Übersichtsarbeit
© Georg Thieme Verlag KG Stuttgart · New York

Komorbiditäten und Mortalität bei Patienten mit entzündlichen Gelenkerkrankungen

Comorbidities and Mortality in Patients with Rheumatic Joint Diseases
Stefan Kleinert
1   Praxisgemeinschaft Rheumatologie – Nephrologie, Rheumatologische Schwerpunktpraxis Erlangen, Erlangen und Med. Klinik 2, Rheumatologie / Klinische Immunologie, Universitätsklinikum Würzburg
› Author Affiliations
Further Information

Publication History

Publication Date:
05 February 2018 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Die entzündlichen Gelenkerkrankungen werden zunehmend als Systemerkrankungen angesehen. Systemische Manifestationen und Komorbiditäten wie kardiovaskuläres Risiko, Fatigue und Depression, Anämie, Osteoporose und erhöhte Mortalität sind in den letzten Jahren zunehmend in den klinischen und wissenschaftlichen Blickpunkt geraten. Infektionsrisiko, chronische Nieren- und Lungenerkrankungen können die Therapie im klinischen Alltag komplizieren. Einschränkungen der Kognition oder der sexuellen Funktion sind dagegen kaum wissenschaftlich erfasst und werden vermutlich auch auf Arzt-Patienten-Ebene unzureichend adressiert. Eine systematische Umsetzung der Erfassung und des Management von Komorbiditäten ist notwendig, um die Mortalität von Patienten mit entzündlichen Systemerkrankungen zu reduzieren und die Lebensqualität zu verbessern. Eine solche Umsetzung wird aber derzeit vom kassenärztlichen System nicht vergütet.

Abstract

Rheumatic joint diseases are increasingly seen as systemic diseases. Systemic manifestations and comorbidities such as cardiovascular risk, fatigue, depression, osteoporosis and increased mortality have gained clinical and scientific attention in recent years. Therapeutic efforts may be complicated by the risk of infection as well as chronic lung or renal diseases. In contrast, cognitive impairment and sexual dysfunction have hardly been evaluated in clinical studies and are probably not sufficiently addressed between patients and clinicians. A systematic approach to evaluate for and manage comorbidities is necessary to reduce mortality and improve quality of life for patients, but is currently not part of reimbursement in the public health sector.

Schlüsselwörter

Entzündlich-rheumatische Erkrankungen - Komorbiditäten - Mortalität - Kardiovaskulär - Fatigue

Key words

rheumatic diseases - comorbidities - mortality - cardiovascular - fatigue
 

  • Literatur

  • 1 Pincus T, Gibson KA, Block JA. Premature mortality: a neglected outcome in rheumatic diseases?. Arthritis Care & Research 2015; 67: 1043-1046
    CrossrefPubMedGoogle Scholar
  • 2 Krause D, Schleusser B, Herborn G. et al. Response to methotrexate treatment is associated with reduced mortality in patients with severe rheumatoid arthritis. Arthritis Rheum 2000; 43: 14-21
    CrossrefPubMedGoogle Scholar
  • 3 Gonzalez A, Maradit Kremers H, Crowson CS. et al. The widening mortality gap between rheumatoid arthritis patients and the general population. Arthritis Rheum 2007; 56: 3583-3587
    CrossrefPubMedGoogle Scholar
  • 4 Listing J, Kekow J, Manger B. et al. Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNFalpha inhibitors and rituximab. Ann Rheum Dis 2015; 74: 415-421
    PubMedGoogle Scholar
  • 5 Markusse IM, Akdemir G, Dirven L. et al. Long-term outcomes of patients with recent-onset rheumatoid arthritis after 10 years of tight controlled treatment: a randomized trial. Ann Intern Med 2016; 164: 523-531
    CrossrefPubMedGoogle Scholar
  • 6 Lacaille D, Avina-Zubieta JA, Sayre EC. et al. Improvement in 5-year mortality in incident rheumatoid arthritis compared with the general population-closing the mortality gap. Ann Rheum Dis 2016; DOI: 10.1136/annrheumdis-2016-209562.
    PubMedGoogle Scholar
  • 7 Agca R, Heslinga SC, Rollefstad S. et al. EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Ann Rheum Dis 2017; 76: 17-28
    CrossrefPubMedGoogle Scholar
  • 8 Schieir O, Tosevski C, Glazier RH et al. Incident myocardial infarction associated with major types of arthritis in the general population: a systematic review and meta-analysis. Ann Rheum Dis 2017 doi:10.1136/annrheumdis-2016-210275
    PubMed
  • 9 Holmqvist M, Ljung L, Askling J. Acute coronary syndrome in new-onset rheumatoid arthritis: a population-based nationwide cohort study of time trends in risks and excess risks. Ann Rheum Dis 2017 doi:10.1136/annrheumdis-2016-211066
    PubMed
  • 10 Kleinert S, Krueger K, Stork S. Risk of atherosclerosis mediated by inflammation in rheumatoid arthritis. Z Rheumatol 2012; 71: 850-858
    CrossrefPubMedGoogle Scholar
  • 11 Kleinert S, Krueger K. Cardiovascular comorbidity and its risk factors in rheumatoid arthritis. Z Rheumatol 2011; 70: 464-472
    CrossrefPubMedGoogle Scholar
  • 12 Krüger K, Kleinert S, Hecker R. et al. Implementation of the EULAR Recommendations for Cardiovascular Risk Management in Germany: Results of a Cross-Sectional Epidemiologic Study [abstr]. Ann Rheum Dis 2014; 73: 172-173
    CrossrefPubMedGoogle Scholar
  • 13 Albrecht K, Huscher D, Eidner T. et al. Medical treatment of rheumatoid arthritis in 2014: Current data from the German Collaborative Arthritis Centers. Z Rheumatol 2017; 76: 50-57
    CrossrefPubMedGoogle Scholar
  • 14 [Anonym]. Daten der Kerndokumentation 2014. Deutsches Rheuma-Forschungszentrum Berlin 2017
    PubMed
  • 15 Strangfeld A, Eveslage M, Schneider M. et al. Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient?. Ann Rheum Dis 2011; 70: 1914-1920
    CrossrefPubMedGoogle Scholar
  • 16 Bawadekar M, Gendron-Fitzpatrick A, Rebernick R. et al. Tumor necrosis factor alpha, citrullination, and peptidylarginine deiminase 4 in lung and joint inflammation. Arthritis Res Ther 2016; 18: 173
    CrossrefPubMedGoogle Scholar
  • 17 Goldacker S, Gause AM, Warnatz K. et al. Vaccination in adult patients with chronic inflammatory rheumatic diseases. Z Rheumatol 2013; 72: 690-694 696-700, 702-694
    CrossrefPubMedGoogle Scholar
  • 18 Kekow J, Moots R, Khandker R. et al. Improvements in patient-reported outcomes, symptoms of depression and anxiety, and their association with clinical remission among patients with moderate-to-severe active early rheumatoid arthritis. Rheumatology (Oxford) 2011; 50: 401-409
    CrossrefPubMedGoogle Scholar
  • 19 Katz P. Causes and consequences of fatigue in rheumatoid arthritis. Curr Opin Rheumatol 2017; 29: 269-276
    CrossrefPubMedGoogle Scholar
  • 20 Durcan L, Wilson F, Cunnane G. The effect of exercise on sleep and fatigue in rheumatoid arthritis: a randomized controlled study. J Rheumatol 2014; 41: 1966-1973
    CrossrefPubMedGoogle Scholar
  • 21 Katz P, Margaretten M, Gregorich S. et al. Physical Activity to Reduce Fatigue in Rheumatoid Arthritis: A Randomized, Controlled Trial. Arthritis Care Res (Hoboken) 2017; DOI: 10.1002/acr.23230.
    PubMedGoogle Scholar
  • 22 Thomsen T, Aadahl M, Beyer N. et al. The efficacy of motivational counselling and SMS reminders on daily sitting time in patients with rheumatoid arthritis: a randomised controlled trial. Ann Rheum Dis 2017; DOI: 10.1136/annrheumdis-2016-210953.
    PubMedGoogle Scholar
  • 23 Oude Voshaar MAH, Steunebrink LMM, Taal E. et al. Determinants of perceived health non-improvement in early rheumatoid arthritis patients with favorable treatment outcomes. Arthritis Care Res (Hoboken) 2017; DOI: 10.1002/acr.23305.
    PubMedGoogle Scholar
  • 24 Kleinert S, Marx A, Faller H. et al. Prevalence and Relevance of Depressive Symptoms in Patients with Rheumatic Diseases [abstract]. Arthritis Rheumatol 2015; 67 (Suppl. 10) 2015
    PubMedGoogle Scholar
  • 25 Englbrecht M, Alten R, Aringer M. et al. Validation of Standardized Questionnaires Evaluating Symptoms of Depression in Rheumatoid Arthritis Patients: Approaches to Screening for a Frequent Yet Underrated Challenge. Arthritis Care Res (Hoboken) 2017; 69: 58-66
    CrossrefPubMedGoogle Scholar
  • 26 Brandstetter S, Riedelbeck G, Steinmann M. et al. Depression moderates the associations between beliefs about medicines and medication adherence in patients with rheumatoid arthritis: Cross-sectional study. J Health Psychol 2016; DOI: 10.1177/1359105316646440.
    PubMedGoogle Scholar
  • 27 DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000; 160: 2101-2107
    CrossrefPubMedGoogle Scholar
  • 28 Shin SY, Katz P, Wallhagen M. et al. Cognitive impairment in persons with rheumatoid arthritis. Arthritis Care Res (Hoboken) 2012; 64: 1144-1150
    CrossrefPubMedGoogle Scholar
  • 29 Appenzeller S, Bertolo MB, Costallat LT. Cognitive impairment in rheumatoid arthritis. Methods Find Exp Clin Pharmacol 2004; 26: 339-343
    CrossrefPubMedGoogle Scholar
  • 30 Shin SY, Julian L, Katz P. The relationship between cognitive function and physical function in rheumatoid arthritis. J Rheumatol 2013; 40: 236-243
    CrossrefPubMedGoogle Scholar
  • 31 Brown SC, Glass JM, Park DC. The relationship of pain and depression to cognitive function in rheumatoid arthritis patients. Pain 2002; 96: 279-284
    CrossrefPubMedGoogle Scholar
  • 32 Bartolini M, Candela M, Brugni M. et al. Are behaviour and motor performances of rheumatoid arthritis patients influenced by subclinical cognitive impairments? A clinical and neuroimaging study. Clin Exp Rheumatol 2002; 20: 491-497
    PubMedGoogle Scholar
  • 33 Wallin K, Solomon A, Kareholt I. et al. Midlife rheumatoid arthritis increases the risk of cognitive impairment two decades later: a population-based study. J Alzheimers Dis 2012; 31: 669-676
    CrossrefPubMedGoogle Scholar
  • 34 Joaquim AF, Appenzeller S. Neuropsychiatric manifestations in rheumatoid arthritis. Autoimmun Rev 2015; 14: 1116-1122
    CrossrefPubMedGoogle Scholar
  • 35 Meade T, Manolios N, Cumming SR. et al. Cognitive Impairment in Rheumatoid Arthritis: A Systematic Review. Arthritis Care Res (Hoboken) 2017; DOI: 10.1002/acr.23243.
    PubMedGoogle Scholar
  • 36 Lee S, Suh Y, Cheon Y. et al. The Relationship Between Disease Activity and Cognitive Impairment in Patients with Rheumatoid Arthritis [abstract]. Arthritis Rheumatol 2015; 67 (Suppl. 10) 2015
    PubMedGoogle Scholar
  • 37 Shin S, Lee J, Yoon B. Factors Associated with Cognitive Impairment in Korean Adults with Rheumatoid Arthritis [abstract]. Arthritis Rheumatol 2016; 68 (Suppl. 10) 2016
    CrossrefPubMedGoogle Scholar
  • 38 Kurizky PS, Mota LM. Sexual dysfunction in patients with psoriasis and psoriatic arthritis – a systematic review. Rev Bras Reumatol 2012; 52: 943-948
    CrossrefPubMedGoogle Scholar
  • 39 Dhakad U, Singh BP, Das SK. et al. Sexual dysfunctions and lower urinary tract symptoms in ankylosing spondylitis. Int J Rheum Dis 2015; 18: 866-872
    CrossrefPubMedGoogle Scholar
  • 40 Sariyildiz MA, Batmaz I, Inanir A. et al. The impact of ankylosing spondylitis on female sexual functions. Int J Impot Res 2013; 25: 104-108
    CrossrefPubMedGoogle Scholar
  • 41 El Miedany Y, El Gaafary M, El Aroussy N. et al. Sexual dysfunction in rheumatoid arthritis patients: arthritis and beyond. Clin Rheumatol 2012; 31: 601-606
    CrossrefPubMedGoogle Scholar
  • 42 Zhang Q, Zhou C, Chen H. et al. Rheumatoid arthritis is associated with negatively variable impacts on domains of female sexual function: evidence from a systematic review and meta-analysis. Psychol Health Med 2017; doi:10.1080/13548506.2017.1338738 1-12
    PubMedGoogle Scholar
  • 43 Lange U, Schett G. Osteoporosis. Z Rheumatol 2016; 75: 442-443
    CrossrefPubMedGoogle Scholar
  • 44 Tony HP. Rheumatism and cancer. Z Rheumatol 2016; 75: 11-12
    CrossrefPubMedGoogle Scholar
  • 45 Dougados M, Soubrier M, Perrodeau E. et al. Impact of a nurse-led programme on comorbidity management and impact of a patient self-assessment of disease activity on the management of rheumatoid arthritis: results of a prospective, multicentre, randomised, controlled trial (COMEDRA). Ann Rheum Dis 2015; 74: 1725-1733
    CrossrefPubMedGoogle Scholar
  • 46 Schuch F, Kern P, Kreher G. et al. Curriculum for "Rheumatology health professionals DGRh-BDRh" as a way of qualification for clinical nursing specialists: Concept and results of an evaluation. Z Rheumatol 2011; 70: 670-677
    CrossrefPubMedGoogle Scholar